Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-07

Clinical Trial Update: A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants [Phase 1]

View source ↗

Summary

A phase 1 study evaluating whether dulaglutide affects the pharmacokinetics of digoxin in healthy participants, providing data on potential drug interaction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dulaglutide (dulaglutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-10-07